VONBIO Co., Ltd. participated in the 2025 Shanghai International Beauty Expo (CBE 2025) held in Shanghai, China fr|om May 12 to 14, 2025. CBE is one of the three largest beauty exhibitions in Asia, featuring over 3,200 participating companies fr|om 80 countries and attracting more than 500,000 visitors. It is a leading event that showcases the latest trends and innovations in the global beauty industry. At this exhibition, we focused on promoting our Glinity brand’s product, GLINITY REJUVEN PN 2%. This high-performance skin booster contains 2% polynucleotide (PN) derived fr|om salmon and is effective in skin regeneration, anti-inflammation, cell activation, and tissue repair, making it especially suitable for damaged or sensitive skin. With its differentiated efficacy and safety, the product attracted strong interest fr|om both local and international buyers. During the exhibition, we held more than 10 meaningful business meetings with buyers fr|om China and Russia, and active discussions are currently underway regarding potential export contracts. Through our participation in the Shanghai expo, we have further solidified our brand presence in the Asian market. Building on this momentum, we plan to participate in upcoming global exhibitions, including the Guangzhou Beauty Expo (CIBE) in September 2025, to accelerate the global expansion of the Glinity brand. Furthermore, we are preparing to launch two new products: the Glinity V-Bottle, a fat-dissolving injectable, and PN 0.2% EYES, a skin booster specially formulated for the delicate under-eye area. By continuously developing high-performance products that meet global market needs, we aim to strengthen our competitiveness in the international aesthetic industry. Thank you.  

  VONBIO Co., Ltd. participated in the 2025 Dubai Derma exhibition held fr|om April 14 to April 16, 2025, in Dubai, UAE. Dubai Derma is a global dermatology and aesthetic exhibition, attracting dermatologists, hospital representatives, and professionals fr|om the aesthetic industry fr|om various countries,  including Europe, Africa, Asia, and the Middle East.   At this exhibition, we showcased the new Glinity Rejuven PN 2% Filler and the Glinity Derma Aesthetic lineup,  focusing on promoting the brand and expanding exports in the Middle Eastern market.  Glinity products received a great response fr|om local buyers due to their high quality and sleek design aimed at the Middle Eastern market. During the exhibition, we had meetings with over 100 buyers, and there was significant interest and inquiries throughout the three-day event. Among the deals made, a contract worth approximately $300,000 was signed with buyers fr|om Iraq and the Kurdistan region,  leading to tangible export results.  Currently, discussions for additional supply and exclusive distribution agreements with various partners in the Middle East are underway, and this exhibition has laid the foundation for further expanding the Glinity brand in the region.   We are also preparing for participation in the China Beauty Expo (CBE) in Shanghai in May and the China International Beauty Expo (CIBE) in Guangzhou in September. With continuous product development and enhanced marketing efforts, we aim to strengthen our presence in the global beauty market. Thank you.    

In March 2025, Vonbio launched the Glinity Rejuven PN 2% Filler.  The company plans to participate in the Dubai Derma and Guangzhou Beauty Exhibitions this year,  with a focus on export growth and active promotion of the Glinity filler line. Vonbio will continue to strengthen its aesthetic product portfolio and expand its presence in global markets.     [Glinity Rejuven PN 2% Filler]   This filler contains PN (polynucleotide) extracted fr|om salmon or trout sperm.  It works in the dermis layer of the skin to enhance brightness and elasticity, provide anti-inflammatory effects, promote cell proliferation,  and support tissue regeneration.     Thank you.  

On January 2, 2025, Vonbio employees gathered at Cheonggyesan Mountain for a New Year’s kickoff hike.  This event was organized to mark the beginning of a healthy year while strengthening communication and unity among colleagues. With perfect weather on our side, we embraced the crisp and refreshing winter air, fully immersing ourselves in the beauty of nature.  As we hiked up the mountain, we enjoyed meaningful conversations and camaraderie with our colleagues.  Step by step, we reached the summit, Maebong Peak, where we captured a commemorative photo and reaffirmed our commitment to a strong start in 2025. The hike was a valuable experience, allowing us to begin the new year with a healthy mind and body.  It also provided an opportunity to share our goals and strengthen our team spirit. As always, we will continue to prioritize the health and happiness of our employees as our core value.  With strong teamwork and unity, we look forward to steady growth and new milestones in the year ahead.     Thank you.

As the year draws to a close, Vonbio embraced its core value of Virtue, underscoring its social responsibility  by sharing warmth and care with the local community during the holiday season of December 2024.   This annual initiative, which began in 2019, marks its fifth year, reflecting the company’s unwavering commitment to the enduring value of giving back.   This year, Vonbio donated monetary contributions alongside its flagship product, Glinity Clostridium Butyricum Comfort Slim-Probiotics,  to various welfare organizations, including children’s centers, disability welfare centers, and comprehensive welfare institutions.   Glinity Clostridium Butyricum Comfort Slim-Probiotics, a next-generation probiotic designed to promote gut health, was gifted with the hope of supporting  the recipients’ journey toward healthier daily lives.  By combining financial donations with product contributions, this year’s effort enriched the value of giving even further.   Vonbio has consistently engaged in charitable activities year after year, providing meaningful assistance to vulnerable groups in society.  The company remains committed to expanding its support to even more neighbors through ongoing philanthropic efforts,  striving to grow as a socially responsible enterprise that embodies the spirit of sharing and compassion.       Thank you.

  In celebration of its 5th anniversary, VONBIO hosted an overseas workshop in Chongqing, China, fr|om October 23 to 26. The main anniversary event on October 25 featured a presentation of VONBIO’s five-year growth story, followed by team-building activities  and various recreational sessions that encouraged communication and interaction among team members.  Key Chinese partners, CQCB and Ensky, also joined, sharing insights on their collaborative achievements and future visions to further solidify  their partnership with VONBIO. During the workshop, CEO Rodic stated, “This workshop provided a meaningful opportunity to reflect on our five-year journey and to reaffirm  our commitment to greater growth in the future. I extend my gratitude to all our team members and partners who have supported us,  and VONBIO will continue to pursue innovation and progress without pause.” Through this workshop, VONBIO has renewed its goals and is dedicated to achieving further growth on the global stage. Thank you.  

  VONBIO Co., Ltd. participated in the "2024 BEAUTY ISTANBUL" exhibition, held fr|om October 2 to October 4, 2024, in Istanbul, Turkey. The BEAUTY ISTANBUL exhibition, now in its fifth year, is a global beauty trade show that attracts buyers fr|om various regions, including Asia, Europe, the Middle East, Africa, and Latin America. At this year's event, VIONBIO showcased its newly launched aesthetic dermal filler line as the main product. With the growing trust and interest in K-beauty,  our products garnered significant attention not only fr|om buyers in Turkey but also fr|om those in Europe, the Middle East, and Africa. In particular, the sleek packaging design and superior performance of our distinctive Glinity product line received enthusiastic responses fr|om buyers. During the exhibition, VONBIO engaged in discussions with over 50 cosmetic and medical device distributors regarding exclusive supply and distribution agreements.  These discussions also included negotiations on concrete export contracts, and the networks established through these talks will serve as a crucial foundation for expanding into local markets, as well as into Europe and the Middle East. Furthermore, VONBIO remains committed to leading new trends in the beauty industry through ongoing research, development, and discovery of new products.  We aim to continuously introduce innovative products that meet diverse customer needs.  We also plan to expand the Glinity product line further to enhance our brand recognition in the global market. Building on the experience and networking gained fr|om this exhibition, we will continue to strengthen the influence of K-beauty by exploring new markets and expanding global partnerships. Thank you.

  Vionbio Co., Ltd. successfully participated in the 2024 Central Asia Beauty Expo held at the Atakent International Exhibition Center in Almaty, Kazakhstan,  fr|om May 30th to June 1st, 2024.  The exhibition attracted over 350 companies fr|om 30 countries worldwide, with approximately 10,000 visitors in attendance.  Within the Korean pavilion, around 25 companies, including ours, took part.   This event marked our first participation in an international exhibition since our establishment.  During the three-day event, we engaged in over 35 fruitful meetings with a total of 130 visitors, laying a significant foundation for entering the global market with our aesthetic dermal filler line in the beauty and healthcare sector.   Of particular note, our booth attracted numerous cosmetics and medical device distributors and retailers fr|om Central Asian and neighboring countries such as Kazakhstan, Russia, and Uzbekistan, emerging markets in the K-beauty industry.  Active discussions regarding product inquiries and supply of our recently launched brand, 'Glinity Filler' line, and cosmetics took place.  The high-quality products and unique packaging received overwhelmingly positive feedback on-site.   Building upon the experience and insights gained fr|om this exhibition, Vionbio Co., Ltd. is committed to driving the global expansion of our future  development products and laying the groundwork for business diversification. We look forward to continuing our efforts to expand into the global market at the Beauty Istanbul Exhibition in Turkey scheduled for September.   Thank you.

Vonbio is proud to announce the launch of our new Glinity Aesthetic Derma Filler Line, an innovative step forward in strengthening our beauty and healthcare portfolio.  This new product line, aimed at the global market, officially debuted in April 2024. Our promotional efforts began in earnest at this year's Kazakhstan Beauty Expo and will continue at Beauty Istanbul.  We are committed to showcasing the Gliniti Filler at various beauty fairs internationally, signaling our active engagement in the global beauty scene. Plans are in place to progressively expand the Glinity Aesthetic Derma Filler line, offering enhanced beauty solutions worldwide.     1. Glinity Hyaluronic Acid (HA) Filler: 3 types (S, M, L) The Gliniti HA Fillers are designed as single-phase products, produced using a specialized grinding machine and a consistent injection process.  These soft gel fillers are crafted to deliver natural-looking results.  They minimize pain and enhance stability during procedures through an optimal cleaning process and an ideal lidocaine content.       2. Glinity L and G Fillers: 2 types L (PLA+HA) and G (PLGA+HA) Our L and G fillers use PLA and PLGA ingredients, approved for safety by the U.S. FDA, to stimulate autologous collagen production. These polymer fillers not only provide natural volume but also represent safe, next-generation technology having passed extensive safety and performance evaluations.     3. Glinity Lip 

We are pleased to announce that the official blog of Vonbio has been opened. (Link to the blog)   Thank you.

In December 2023, VONBIO carried out donations to Muncheon Welfare Center and Gwangjin Welfare Foundation as part of its social contribution efforts. This donation, made with the hope of helping the marginalized communities in the local area, is intended to be used for various support activities targeting low-income families and the elderly. VONBIO is committed to continuously engaging in contribution activities that reach out to the overlooked sectors of society. We hope that our small donation becomes a significant first step in bringing about substantial change.  VONBIO aspires to be a company that practices the values of love and sharing. Thank you.

  VONBIO attended 'CPhI Worldwide 2023', the world's largest pharmaceutical and biotech exhibition, held in Barcelona, Spain, fr|om October 24th to 26th over three days. During the event, we actively promoted the export of our 'Glinity' products, operating a joint booth with our overseas partners. We also focused on strengthening business cooperation and discovering new trading partners through local meetings with existing overseas partners, which had been challenging over the past three years due to COVID-19. After the exhibition, we held a two-day workshop in Barcelona and Madrid to commemorate our 4th anniversary. This included various local tours and activities, such as exploring Gaudi's architectural works, the Royal Palace of Madrid, and a humanities tour of the Prado Museum, which allowed us to experience the language, history, and culture of Spain, and gain valuable insights. Moreover, we enjoyed a pleasant time of refreshment through various gaming events and award ceremonies. This participation in the CPhI Worldwide exhibition and workshop served as an opportunity for enhancing employee job competencies and fostering unity and communication. In the future, we will continue to strive towards a healthy organizational culture that encourages mutual consideration and support, focusing on growth as positive and passionate talents. Thank you.  

Hello, This is Vonbio. We are pleased to announce that as of June 15th, we have launched our Clostridium Butyricum Comfort Slim-Probiotics  under our self-brand Glinity, as part of our inner beauty lineup. Butyric acid bacteria is a type of probiotic beneficial to our body. It is a bacterium that can produce butyric acid, a core substance in our intestines. Resistant to high temperatures and stomach acid, it boasts a survival rate of over 90% in the intestines. By promoting the growth of beneficial bacteria and inhibiting harmful ones, it helps maintain a healthy intestinal flora. Moving forward, we are committed to diversifying our lineup of beauty and food products  by continually integrating competitive raw materials and new technologies. We appreciate your interest and support.  Thank you. Website : http://glinity.co.kr    

Vonbio visited the 'Natural Products Expo' held at the Anaheim Convention Center in the United States fr|om March 8th (Wed) to 12th (Sun). Through the world's largest comprehensive exhibition of natural, organic, and health-related products, we were able to recognize the latest trends in the industry and gain an opportunity to understand global trends. Vonbio plans to launch a butyric acid bacteria probiotics product in May 2023 and will continue to do its best in developing valuable healthcare products.

Vonbio visited the Dubai Arab Health exhibition fr|om January 30th (Mon) to February 2nd (Thu). In order to make 2023 the first year of successful exports, we will maximize our overseas export and new product licensing opportunities through continuous and focused visits to overseas clients and thoroughly planned promotions. We will gradually expand our foothold for overseas expansion through various channels, and our company will actively invest available resources for overseas exports, focusing our efforts on the development of new products that can succeed in overseas markets.

Hello. This is VONBIO.   We introduce our new items as follows.     Thank you.  VONBIO CO.,LTD.